Biochem/physiol ActionsInhibits ADP-induced platelet aggregation; anti-thrombotic drug.
Features and BenefitsThis compound is a featured product for ADME Tox research.
Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at
sigma.com/discover-bsm.
This compound is featured on the
P2 Receptors: P2Y G-Protein Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages,
click here.
This compound was developed by
Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates,
click here.
PackagingStore under desiccant